MediTox s.r.o.


Main activities

Non clinical R & D related to ophthalmic diseases (chronic glaucoma), osteoarthritis (ACLT, CCLT, dogs, rabbits), non-clinical development of vaccines (influenza, adenovirus, etc.).

Comprehensive non-clinical and toxicological program for assessment of human/veterinary drugs, vaccines, biological products, medical devices and food/feed additives (EMA/ICH/VICH/FDA/ISO), chemical substances and preparations (ECHA)

Models of selected human diseases - chronic glaucoma, contact dermatitis, osteoarthritis, human influenza, periodontitis

Accredited breeding facility (CZ 02396)

MediTox s.r.o.

MediTox s.r.o. is a GLP-certified preclinical contract research organization offering a wide range of preclinical development services taking advantage of wealth of experience in variety of therapeutics areas, biotechnology, chemical and agrochemical industry and research collaboration with universities and research institutions.


MediTox R&D activities are pointed to collaborative scientific and research projects within international and national framework.


The strong points of MediTox ensure personalized and comprehensive contract research (one-stop-shop), high professional standard together with flexibility and competitive pricing.



We will attend following events:

4th Hellenic Biocluster Forum, March 06 – 07, 2025, Athens

4th Hellenic Biocluster Forum



Swiss Biotech Day, May 5 – 6, 2025, Basel

Swiss Biotech Day 2025



BIO International Convention, June 16 – 19, 2025, Boston

BIO International Convention 2025



Life Sciences Baltics, September 17 – 18, 2025, Vilnius

Life Sciences Baltics 2025



BioSpain 2025, September 2025, Madrid

BioSpain 2025



Nordic Life Science Days, October 13 – 14, 2025, Gothenburg

Nordic Life Science Days 2025



BIO-EUROPE, November 3 – 5, 2025, Vienna

BIO-EUROPE 2025



MediTox s.r.o.

MediTox s.r.o.

MediTox s.r.o.